References
- Tsimberidou A-M, Van Morris K, Henry Hiep V, et al. T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors. J Hematol Oncol. 2021;14(1):102. doi:10.1186/s13045-021-01115-0
- Mirzaei HR, Rodriguez A, Shepphird J, Brown CE, Badie B. Chimeric Antigen receptors t cell therapy in solid tumor: challenges and clinical applications. Front Immunol. 2017;8:1850. doi:10.3389/fimmu.2017.01850
- Leon E, Ranganathan R, Savoldo B. Adoptive T cell therapy: boosting the immune system to fight cancer. Semin Immunol. 2020;49:101437. doi:10.1016/j.smim.2020.101437
- Paijens ST, Vledder A, de Bruyn M, Hans W. Nijman.Tumor-infiltrating lymphocytes in the immunotherapy era. Cell Mol Immunol. 2021;18(4):842–859. doi:10.1038/s41423-020-00565-9
- Creelan BC, Wang C, Teer JK, et al. Landin, et al.Tumor-infiltrating-lymphocyte treatment for anti-PD-1 resistant metastatic lung cancer: a Phase I trial. Nat Med. 2021;27(8):1410–1418. doi:10.1038/s41591-021-01462-y
- Tang Y, Zhang AXJ, Chen G, Wu Y, Gu W. Prognostic and therapeutic TILs of cervical cancer Current advances and future perspectives. Mol Ther Oncolytics. 2021;22:410–430. doi:10.1016/j.omto.2021.07.006
- Rohaan MW, van den Berg JH, Kvistborg P, Haanen JBAG. Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option. J Immunother Cancer. 2018;6(1):102. doi:10.1186/s40425-018-0391-1
- Brisson M, Kim JJ, Canfell K, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):575–590. doi:10.1016/S0140-6736(20)30068-4
- Finocchario-Kessler S, Wexler C, Maloba M, Mabachi N, Ndikum-Moffor F, Bukusi E. Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective. BMC Women's Health. 2016;16:29. doi:10.1186/s12905-016-0306-6
- T GD, Giannini A, Bogani G, et al. Prevention, screening, treatment and follow-up of gynecological cancers: state of art and future perspectives. Clin Exp Obstet Gynecol. 2023;50(8):160. doi:10.31083/j.ceog5008160
- Zhu Y, Zhou J, Zhu L, Wenjing H, Liu B, Xie L. Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer. Hum Vaccin Immunother. 2022;18(5):2060019. doi:10.1080/21645515.2022.2060019
- Ruan H, Oike T, Sato H, Ando K, Ohno T. Association between Tumor Mutational Burden, Stromal CD8+ Tumor-Infiltrating Lymphocytes, And Clinical Factors In Cervical Cancers Treated with Radiotherapy. Cancers. 2023;15(4):1210. doi:10.3390/cancers15041210
- Liu C, Li X, Huang Q, et al. Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer. Signal Transduct Target Ther. 2023;8(1):44. doi:10.1038/s41392-022-01264-9
- Liu C, Zhang M, Yan X, et al. Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression. Sci Adv. 2023;9(4):eadd8977. doi:10.1126/sciadv.add8977